NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world. The scope of the NIAID research portfolio has expanded considerably in recent years in response to new challenges such as bioterrorism, emerging and re-emerging infectious diseases, and the increase in asthma prevalence among children in the United States.
The growth of NIAID programs has also been driven by unprecedented scientific opportunities in the core NIAID scientific disciplines of microbiology, immunology, and infectious diseases. Advances in these key fields have led to a better understanding of the human immune system and the mechanisms of infectious and immune-mediated diseases.
Recent Congressional Testimony by Director Anthony S. Fauci, M.D.
back to top
Last Updated February 09, 2016